IP patients, thus, had a strikingly high prevalence of auto-Abs against type I IFNs neutralizing IFN-α subtypes and/or IFN-ω, and this prevalence (∼40%) was stable from the age of 6 years onwards (Fig. 1 C). This evidence concerns the gene IFNA2 and incontinentia pigmenti.